# Sigurdur Y. Kristinsson

Source: https://onco.cc/people/sigurdur-kristinsson/  
OnCo record `sigurdur-kristinsson` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Leads iStopMM, which screened most of Iceland's adults for myeloma precursors to test whether early detection helps.

## Summary

Sigurdur Kristinsson (University of Iceland) leads iStopMM, the nationwide study that invited every Icelander over 40 to be screened for monoclonal gammopathy and randomised those found to have MGUS to different follow-up strategies, the first population-based test of whether screening for a myeloma precursor improves outcomes. The study has already refined MGUS prevalence and progression estimates and identified smouldering myeloma in the population.

## Fields

- Kind: Person
- Last checked: 2026-09-10
- Tags: myeloma; screening; epidemiology
- Role: Professor of Hematology, University of Iceland; Landspitali University Hospital
- Specialisms: Myeloma precursor conditions; Population screening; Epidemiology; MGUS

## Sources

- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Kristinsson%20SY%5BAuthor%5D%20iStopMM

## Connected records

- cancers: [Multiple myeloma](https://onco.cc/cancers/multiple-myeloma/)
- institutions: [Landspítali, the National University Hospital of Iceland](https://onco.cc/institutions/landspitali/)
- trials: [iStopMM](https://onco.cc/trials/istopmm/)
- journals: [Blood cancer journal](https://onco.cc/journals/blood-cancer-journal/)

---
JSON: https://onco.cc/api/v1/entities/sigurdur-kristinsson.json